SYNTHESIS AND PRELIMINARY EVALUATION OF AN IODOVINYL-TETRABENAZINE ANALOG AS A MARKER FOR THE VESICULAR MONOAMINE TRANSPORTER

被引:12
作者
CANNEY, DJ [1 ]
GUO, YZ [1 ]
KUNG, MP [1 ]
KUNG, HF [1 ]
机构
[1] UNIV PENN,DEPT PSYCHIAT,PHILADELPHIA,PA 19104
关键词
VESICULAR MONOAMINE TRANSPORTER; I-125; RADIOIODINATED TETRABENAZINE ANALOG;
D O I
10.1002/jlcr.2580330413
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A derivative of tetrabenazine (TBZ, 1) containing an iodovinyl group (I-TBZ, 3b) was prepared as a potential radiotracer for the vesicular monoamine transporter. The synthesis of 3a was achieved by ethynylation of TBZ. The ethynyl derivative 4, was converted to the corresponding vinylstannane 5. The vinylstannane intermediate was then treated with I2 in chloroform at room temperature, to afford the iodovinyl compound (3a, I-TBZ). The no-carrier-added ([I]I-TBZ)-I-125 (3b) was prepared by treating an ethanolic solution of 5. with sodium[I-125]iodide in the presence of H2O2. Following i.v. injection, ([I]I-TBZ)-I-125 (3b) can readily cross the blood brain barrier and localize in the brain (0.92 and 0.36 % dose/organ, at 2 min and 30 min, respectively). However, no specific regional uptake of the ligand was observed. Subsequent biodistribution studies performed using two well resolved peaks obtained from chiral HPLC separation of 3b, demonstrated that Fraction I displayed higher brain uptake (0.6 % dose/organ, 20 min) than the latter peak (Fraction II, 0.3 % dose/organ, 20 min). Fraction I also exhibited a modest degree of specificity for the striatum which could be blocked by pretreatment with tetrabenazine. The high lipophilicity of 3a (P(o/b) for Fraction 1 and II = 1723 and 1395, respectively) may contribute to high nonspecific binding in vivo, and result in the low target/nontarget ratio observed for this compound. Iodovinyl-TBZ analog 3b is a poor candidate as a SPECT imaging agent for the vesicular monoamine transporter.
引用
收藏
页码:355 / 368
页数:14
相关论文
共 30 条
  • [1] SYNTHESIS, RECEPTOR-BINDING, AND TISSUE DISTRIBUTION OF (17-ALPHA,20E)-21-[I-125]IODO-19-NORPREGNA-1,3,5(10),20-TETRAENE-3,17-DIOL AND (17-ALPHA,20Z)-21-[I-125]IODO-19-NORPREGNA-1,3,5(10),20-TETRAENE-3,17-DIOL
    ALI, H
    ROUSSEAU, J
    GHAFFARI, MA
    VANLIER, JE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (10) : 1946 - 1950
  • [2] SYNTHESIS, RECEPTOR-BINDING, AND TISSUE DISTRIBUTION OF 7-ALPHA-SUBSTITUTED AND 11-BETA-SUBSTITUTED (17-ALPHA,20E)-21-[I-125]IODO-19-NORPREGNA-1,3,5(10),20-TETRAENE-3,17-DIOLS AND (17-ALPHA,20Z)-21-[I-125]IODO-19-NORPREGNA-1,3,5(10),20-TETRAENE-3,17-DIOLS
    ALI, H
    ROUSSEAU, J
    GHAFFARI, MA
    VANLIER, JE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) : 854 - 860
  • [3] SYNTHESEVERSUCHE IN DER EMETIN-REIHE .1. 2-OXO-HYDROBENZO[A]CHINOLIZINE
    BROSSI, A
    LINDLAR, H
    WALTER, M
    SCHNIDER, O
    [J]. HELVETICA CHIMICA ACTA, 1958, 41 (01) : 119 - 139
  • [4] SERIES OF HEXAHYDRO[1,4]OXAZINO[3,4-A]ISOQUINOLINES AS POTENTIAL NEUROLEPTICS
    CLARKE, FH
    HILL, RT
    KOO, J
    LOPANO, RM
    MASEDA, MA
    SMITH, M
    SOLED, S
    VONVEH, G
    VLATTAS, I
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (08) : 785 - 791
  • [5] COOPER JR, 1986, BIOCH BASIS NEUROCHE, P290
  • [6] QUANTITATIVE AUTORADIOGRAPHY OF THE RAT-BRAIN VESICULAR MONOAMINE TRANSPORTER USING THE BINDING OF [H-3] DIHYDROTETRABENAZINE AND 7-AMINO-8-[I-125]IODOKETANSERIN
    DARCHEN, F
    MASUO, Y
    VIAL, M
    ROSTENE, W
    SCHERMAN, D
    [J]. NEUROSCIENCE, 1989, 33 (02) : 341 - 349
  • [7] DASILVA JN, 1992, 9TH INT S RAD CHEM, P257
  • [8] FAHRENHOLTZ KE, 1967, J MED CHEM, V9, P304
  • [9] 2-THIO-1,3,4,6,7,11B-HEXAHYDRO-9,10-DIMETHOXY-2H-BENZO[A]QUINOLIZINES
    HARNDEN, MR
    SHORT, JH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (06) : 1183 - &
  • [10] RADIOLIGANDS OF THE VESICULAR MONOAMINE TRANSPORTER AND THEIR USE AS MARKERS OF MONOAMINE STORAGE-VESICLES
    HENRY, JP
    SCHERMAN, D
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (15) : 2395 - 2404